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A model for cGMP signal transduction in Dictyostelium in perspective of 25 years of
cGMP research
LEONARD BOSGRAAF and PETER J. M. VAN HAASTERT*
Department of Biochemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
Abstract
The chemoattactant mediated cGMP response of Dictyostelium cells was discovered about twenty-ﬁve years ago.
Shortly thereafter, guanylyl cyclases, cGMP-phosphodiesterases and cGMP-binding proteins were detected already
in lysates, but the encoding genes were discovered only very recently. The deduced proteins appear to be very
diﬀerent from proteins with the same function in metazoa. In this review we discuss these new ﬁndings in perspective
of the previously obtained biochemical and functional data on cGMP in Dictyostelium.
Introduction
Vegetative Dictyostelium discoideum cells can respond
chemotactically to a number of chemicals that are
secreted by bacteria, their natural food source. Among
these compounds is folic acid, the most studied chemo-
attractant in growing Dictyostelium discoideum cells.
When bacteria are scarce, cells become sensitive to
cAMP that serves as the ﬁrst messenger in cell aggre-
gation. About 25 years ago, it was discovered that
cGMP is produced intracellularly when cells are exposed
to chemoattractants; the presence of cGMP in Dictyo-
stelium had already been suggested 2 years earlier (Put-
nam and Pedersen, 1975). Probably the ﬁrst experiment
was performed with an pterin-like compound puriﬁed
from yeast extract that speciﬁcally attracts Dictyostelium
lacteum. This experiment was designed to investigate the
activation of adenylyl cyclase in a species that does not
use cAMP as chemoattractant. No changes in cAMP
levelswere observed upon stimulationwith the attractant,
but instead a rapid and large increase of intracellular
cGMP was detected in the same extracts (Mato and
Konijn, 1977). Subsequent experiments with folic acid or
cAMP stimulation of Dictyostelium discoideum cells
resulted in a similar cGMP response (Mato et al.,
1977a; Wurster et al., 1977). Shortly hereafter, cGMP-
degrading and cGMP-producing activities were found in
Dictyostelium lysates (Mato et al., 1977b; Ward and
Brenner, 1977), as well as cGMP-binding activity (Mato
et al., 1978). In the 1980s several mutants were isolated
displaying aberrant cGMP metabolism as well as altered
chemotaxis, suggesting that cGMP plays a role in
chemotaxis. Recently we identiﬁed the genes encoding
guanylyl cyclases, cGMP-phosphodiesterases and
cGMP-binding proteins (Roelofs et al., 2001b,c; Bos-
graaf et al., 2002a; Goldberg et al., 2002), that probably
constitute the main components of the cGMP signal
transduction pathway. The encoding proteins appear to
be very diﬀerent from proteins with the same function in
metazoa, and therefore their biochemistry is not always
easily interpreted. The aim of this review is to discuss the
previously obtained biochemical and functional data on
cGMP in Dictyostelium in the perspective of the recently
identiﬁed genes.
Guanylyl cyclases
Guanylyl cyclases (GCs) are enzymes that catalyze the
formation of cGMP from GTP (Figure 1) and are found
in a wide variety of organisms, including protozoa,
vertebrates, and cyanobacteria. The ﬁrst experiments in
Dictyostelium showed that the GC activity can be
activated considerably by chemoattractants and is also
enhanced by ATP and non-hydrolyzable GTP ana-
logues (Mato and Malchow, 1978; Mato, 1979; Janssens
and de Jong, 1988; Janssens et al., 1989). Initially, the
activity was found to be Mn2+ dependent and almost
exclusively cytosolic (Padh and Brenner, 1984). Later it
was discovered that activity with the more physiological
cofactor Mg2+ is restricted to the membrane and under
these conditions ATP inhibits the enzyme (Janssens
et al., 1987). The enzyme, which is inhibited by Ca2+
ions (Janssens and de Jong, 1988; Valkema and Van
Haastert, 1992), was found to be partially or loosely
attached to the membrane (Mato and Malchow, 1978;
Padh and Brenner, 1984; Janssens et al., 1987).
The cloning of the Dictyostelium cyclases
In the Dictyostelium genome, eight cyclase domains can
be recognized, four of which encode adenylyl cyclase
(AC) domains. The aggregation-speciﬁc ACA is a
classical AC containing 12 transmembrane regions and
two cyclase domains. On the other hand, the germination
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speciﬁc ACG has the topology of a GC containing one
cyclase domain and one membrane spanning region. The
developmental AcrA has seven predicted transmem-
brane spanning regions and one cyclase domain. The
other four cyclase domains are GCs that are encoded by
two recently cloned genes (Roelofs et al., 2001b,c). A
double knock-out, in which both genes were inactivated,
had no detectable cGMP anymore, suggesting these are
the only two GCs in Dictyostelium discoideum (Roelofs
and Van Haastert, 2002). Interestingly, both proteins
have the topology of ACs. In soluble GC (sGC) the two
cyclase domains are in the same molecule, whereas
classical metazoan soluble GCs are composed of two
proteins that form a heterodimer.Dictyostelium guanylyl
cyclase A (GCA) has 12 membrane spanning regions,
whereas conventional membrane-bound GCs have only
one transmembrane region. The topology of GCA has
also been observed in other protozoan GCs (Linder and
Schultz, 2002).
Properties of the guanylyl cyclases
Although the proteins are very diﬀerent in topology, the
biochemical properties of GCA and sGC display many
similarities (Roelofs and Van Haastert, 2002): Both
enzymes are activated in vivo by folic acid and cAMP
and addition of GTPcS in vitro leads to similar
stimulation of the enzymes (1.5-fold increase of Vmax
and 3.5-fold increase of Km for GTP). Furthermore,
both enzymes are inhibited by Ca2+ ions though the
inhibition constants are somewhat diﬀerent (50 nM for
GCA and 200 nM for sGC). Disruption of the sgc gene
reduces GC activity to about 30% in vegetative cells and
to about 10% in aggregation-competent cells. Another
diﬀerence between the two enzymes is the relative
activity in the presence of bivalent cations: sGC is 5-
fold more active with 2 mM Mn2+ than with 2 mM
Mg2+, whereas GCA is 3-fold less active with Mn2+
than with Mg2+. For sGC the Mn2+- and Mg2+-
dependent activities represent diﬀerent subpopulations
of the enzyme (Roelofs et al., 2001b). With Mn2+ most
of sGC activity is soluble and is aﬀected by neither
GTPcS nor calcium ions, while with the more physio-
logical Mg2+, the activity is restricted to the particulate
fraction and is strongly stimulated by GTPcS and
inhibited by Ca2+. Experiments in which particulate
and cytosolic fractions of diﬀerent mutants where mixed
indicated that calcium inhibits membrane association of
sGC, thus blocking its Mg2+-dependent activity (J.
Roelofs and P.J.M. Van Haastert, unpublished results).
Both sGC and GCA are aﬀected similarly by GTPcS
(Roelofs and Van Haastert, 2002), which by itself is a
poor substrate for total GC activity (Schulkes et al.,
1992). This suggests that both enzymes are activated via
a similar mechanism, which involves a GTP-binding
protein. In vivo, stimulation of GC activity is completely
dependent on the heterotrimeric G-protein Ga2bc
(Okaichi et al., 1992; Carrel et al., 1994; Wu et al.,
1995; Root et al., 1999). However, several indications
suggest that GTPcS-mediated activation of sGC and
GCA in vitro is not due to the activation of a
heterotrimeric G-protein. For example, in cells lacking
the only known Gb subunit, GC activity can still be
activated by GTPcS (Wu et al., 1995). Further evidence
comes from a study in which GCA was converted to an
AC by introducing three point mutations (Roelofs et al.,
2001). Remarkably, the protein retained its GTPcS
dependence, also when expressed in Gb-null or Ga2/4
double null cells. The properties of GTPcS-stimulation
are consistent with a mechanism that involves a small
GTP-binding protein of the Ras superfamily. This is
supported by the observation that disruption of the gene
encoding the putative Ras exchange factor AleA or the
gene coding for the Ras interacting protein RIP3 led to a
marked reduction of the cAMP-induced cGMP re-
sponse (Lee et al., 1999). Furthermore, the small
G-protein Rap1 was found to be involved in osmotic
shock induced cGMP formation, since introduction of
antisense RNA inhibited this response (Kang et al.,
2002). A model for the regulation of GCA and sGC is
presented in Figure 2.
Phosphodiesterase
The activation of GC upon receptor stimulation is
transient and is inhibited with a t1/2 of about 15 s
(Schoen et al., 1996). Because the cGMP is rapidly
Fig. 1. Structure of cGMP, its precursor GTP and its breakdown product GMP.
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degraded inside the cell, this leads to a short burst of
cGMP. The degradation of cGMP to GMP is accom-
plished by speciﬁc enzymes called phosphodiesterases
(PDEs) (Figure 1). In Dictyostelium, a cGMP-speciﬁc
PDE activity was observed that can be separated from
cAMP-PDE activity (Dicou and Brachet, 1980). Already
the ﬁrst report on cGMP-PDE activity reported that the
enzyme activity displays positive cooperativity (Mato
et al., 1977b). Subsequent experiments using a number
of cGMP-derivatives indicated that hydrolysis of cGMP
and activation of the enzyme by cGMP occur at
diﬀerent sites of the protein (Van Haastert et al., 1982;
Kesbeke et al., 1985). The enzyme can be activated
about 4-fold by cGMP or 8-Br-cGMP, which is a poorly
hydrolysed cGMP-analogue that preferentially binds to
the activator site (Van Haastert and Van Lookeren
Campagne, 1984). The identiﬁcation of chemically
mutated cells that lack all or almost all cGMP-stimu-
lated cGMP-PDE activity has provided a useful tool to
study the cGMP-regulated cGMP-PDE in Dictyostelium
(Ross and Newell, 1981; Van Haastert et al., 1982).
These mutants are referred to as ‘Streamer F’ since they
form abnormally large aggregation streams when plated
on bacteria. Due to the strongly reduced cGMP-PDE
activity, these cells exhibit a four times prolonged and 2-
fold augmented cGMP response.
Cloning of the phosphodiesterases
In Dictyostelium six PDE encoding genes have been
cloned thus far; we propose to address the proteins as
PDE1-6 in the order of their cloning (see Figure 3).
PDE1 is a dual speciﬁcity enzyme encoded by the pdsA
gene and has an important role in degrading extracel-
lular cAMP (Podgorski et al., 1988). The intracellular
cAMP is degraded predominantly by the regA gene
product (PDE2), which not only bears a cAMP-speciﬁc
PDE domain, but also an N-terminal receiver domain
that forms a functional phospho-relay system with the
rdeA phospho-transfer protein (Chang et al., 1998;
Shaulsky et al., 1998; Thomason et al., 1998, 1999).
Based on sequence data, PDE4 is a putative cAMP-PDE
that has two transmembrane segments and an extracel-
lular catalytic domain; the gene is expressed predomi-
nantly in the later stages of development (S. Bader et al.,
unpublished observations).
Apart from the non-speciﬁc extracellular PDE1, no
cGMP-degrading PDEs had been cloned until 2 years
ago. The contribution of PDE1 to intracellular cGMP
degradation is low since this enzyme is found mainly on
the cell surface and in the extracellular space. However,
since cell lysates contain considerable amounts of this
very active enzyme, probably on its way to secretion,
PDE1 masks cGMP-speciﬁc PDE activity unless the
enzyme is inhibited by dithiotreitol. Recently, the
sequencing of the Dictyostelium discoideum genome
has proven fruitful, since three cGMP-PDEs have been
identiﬁed in the past 2 years.
Firstly, a cGMP-speciﬁc PDE termed DdPDE3 was
identiﬁed that contains a catalytic site which shows high
sequence homology with mammalian PDEs (Kuwayama
et al., 2001). Apart from a 300 amino acid catalytic
domain the predicted protein only contains a N-terminal
Asp- and Gln-rich domain with no clues for a regulatory
Fig. 2. Schematic overview of the activation of Dictyostelium guanylyl
cyclases. Upon cAMP stimulation, the cAMP receptor (cAR1)
transmits the signal via the heterotrimeric G-protein Ga2bc to a small
G-protein (Gsmall), which in turn activates the membrane-bound
GCA and the soluble sGC. The sGC binds to the membrane via an
unknown factor shown in green.
Fig. 3. Schematic overview of the relative activity of the six identiﬁed
Dictyostelium phosphodiesterases. Dictyostelium cells have three func-
tional pools of cyclic nucleotides: extracellular cAMP as chemoatt-
ractant, intracellular cAMP as inducer of gene expression and
intracellular cGMP as second messenger for chemotaxis. The relative
contribution of the concerned PDE to the total cAMP- or cGMP-
degrading activity of each pool is indicated by the thickness of the
arrows. The numbers of the PDEs are deﬁned in the table below, which
also contains the original names of the genes, acronyms, and the main
characteristics of the enzymes.
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function. The other two cGMP-PDEs were unexpected-
ly discovered in a search for cGMP targets and were
termed cGMP-binding protein A and B (GbpA and
GbpB) or PDE5 and PDE6 respectively because they
were the ﬁfth and sixth PDEs that were cloned in
Dictyostelium (see table in Figure 3) (Bosgraaf et al.,
2002a,b; Goldberg et al., 2002). Both enzymes contain
two tandem C-terminal cyclic nucleotide binding do-
mains (cNBD) that probably serve as allosteric cGMP-
binding sites for a metallo b-lactamase domain that
comprises the catalytic center (Meima et al., 2002). The
domain topology of PDE5 and PDE6 is very unusual: in
all other identiﬁed cyclic nucleotide activated PDEs the
allosteric sites are formed by GAF domains (Aravind
and Ponting, 1997; Conti and Jin, 1999) that are
structurally entirely unrelated to cNBDs, and cGMP is
hydrolyzed by a type I PDE domain that is unrelated to
the b-lactamase domain.
Properties of the phosphodiesterases
The DdPDE3 protein was analyzed by overexpression in
Dictyostelium and E. coli (Kuwayama et al., 2001),
which revealed that the enzyme has a high aﬃnity for
cGMP (0.22 lM), high selectivity for cGMP over cAMP
(670:1) and a low Vmax (2 pmol/min/mg). The relative
contribution of DdPDE3 to cGMP degradation in vivo
is highest when the cGMP concentration is low because
the activity of DdPDE3 cannot be stimulated by cGMP
or 8-Br-cGMP and the enzyme is easily saturated due to
its low Vmax and Km values. Thus the main function of
this enzyme seems to be the maintenance of low basal
cGMP levels.
Cell lines in which the gene coding for PDE5 has been
disrupted have lost all cGMP-activated cGMP-PDE
activity and show a cAMP-induced cGMP response
reminiscent of that of StmF mutants (Bosgraaf et al.,
2002b; Meima et al., 2002). The biochemical properties
of PDE5 as examined in knock-out and overexpression
studies are identical to that of the StmF enzyme (Km 5.2
and 20 lM for unstimulated and stimulated activity
respectively, Vmax 390 pmol/min/mg, KA 160 nM),
strongly suggesting that PDE5 is not active in these
Streamer mutants. However, we have not been able to
identify the primary defect in StmF strain NP368 as no
mutations in the gene coding for PDE5 were found that
could explain the defective PDE activity. StmF strain
NP377 shows reduced PDE5 mRNA levels, but also no
mutation in the gene causing this eﬀect was found
(Meima et al., 2002).
Overexpression of PDE6 in a pde5)/pde6) cell line
showed that PDE6 is a dual speciﬁcity enzyme with
9-fold higher activity towards cAMP than towards
cGMP (Km 200 lM for cAMP and 800 lM for cGMP;
Vmax 5200 pmol/min/mg for cAMP and 2400 pmol/
min/mg for cGMP) (Bosgraaf et al., 2002b). Interest-
ingly, the enzyme can be activated by both cGMP and
cAMP, the latter being the most potent (KA 2.3 and
0.7 lM respectively). This observation indicates that
cAMP- and cGMP-levels can inﬂuence each other via
PDE6. Mutants with a deletion of the gene coding for
PDE6 show a nearly normal cGMP response, but an
enhanced cAMP response, in agreement with cAMP
being the better substrate of the enzyme. The notion
that intracellular cAMP is the main physiological
substrate of PDE6 is also suggested by the observation
that pde6 null cells are sporogenous, as are mutants that
lack the cAMP-speciﬁc enzyme RegA (Shaulsky et al.,
1998).
PDE5 comprises the main intracellular cGMP hydro-
lyzing activity in Dictyostelium and it can be calculated
that at cGMP peak concentrations (1 lM), it makes up
about 78% of the total cGMP-degrading activity
(Bosgraaf et al., 2002b). Although disruption of PDE6
in a wild-type background does not lead to an enhanced
cGMP response, disruption in a pde5-null cell line leads
to a dramatically enhanced cAMP-induced cGMP
response. This very large cGMP response in pde5/pde6
double null cells is completely wiped out upon 50-fold
overexpression of PDE6. These observations indicate
that PDE6 does hydrolyze cGMP, but is much less
active than PDE5. We estimate that PDE6 contributes
only about 5% to the total cGMP-degrading activity at
cGMP peak concentrations and the main function of
this enzyme is probably cAMP degradation in multi-
cellular development. Summarizing, six PDEs have
been identiﬁed in Dictyostelium, four of which can de-
grade cGMP. The relative contribution of each of these
enzymes to the total cyclic nucleotide degrading activity
is indicated by the thickness of the arrows in Figure 3.
cGMP-binding activity
Shortly after cGMP was found to be present in Dictyo-
stelium discoideum, cGMP-binding activity was also
demonstrated (Mato et al., 1978; Rahmsdorf and Geri-
sch, 1978). This activity, which was found to be mainly
soluble, appeared to be very labile, which might account
for the rather diverse characteristics that have been
reported over time. The cGMP binding was unaﬀected
by EGTA, CaCl2, ATP, 5¢-AMP or 5¢-GMP, whereas
cAMP was found to be inhibitory at >1000 times higher
concentrations (see also Van Haastert et al., 1982). In
one study a single cGMP-binding fraction eluted from a
DEAE-cellulose column with an apparent mass of
several hundred thousand dalton (Rahmsdorf and Ge-
risch, 1978). In another study, three peaks containing
cGMP-binding activity were separated by gel ﬁltration
chromatography, of which the largest had an apparent
mass of 250 kDa (Mato et al., 1979). Several other
studies also described multiple fractions that display
cGMP-binding capacity, but these were proposed to be
degradation products of a larger protein (Parissenti and
Coukell, 1989). The number of cGMP-binding sites is a
few thousand per cell with a Kd between 0.5 and 5 nM
(Mato et al., 1978, 1979; Van Haastert et al., 1982;
Parissenti and Coukell, 1986).
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Whereas in other organisms the cGMP-activated
protein kinase PKG is a major target of cGMP, no
protein kinase activity was associated with the partly
puriﬁed cGMP-binding activity from Dictyostelium
when using histone 2a, histone type VII or Kemptide
as a substrate (Rahmsdorf and Gerisch, 1978; Mato
et al., 1979; Parissenti and Coukell, 1986). However, in
a separate study a protein kinase was puriﬁed with an
antibody, which was found to be activated 3-fold by
cGMP or cAMP with half-maximal activation at 1 and
20 nM respectively (Wanner and Wurster, 1990). The
labile kinase preparation phosphorylated histone 2b but
not Kemptide and histone 2a, and contained several
components with a molecular weight range of 20–
130 kDa. Unfortunately, the cGMP-binding activity
and other biochemical characteristics were not further
determined, leaving open the question whether this
enzyme also comprises the main cGMP-binding activity
in Dictyostelium.
Parissenti and Coukell (1989) reported the isolation
and stabilization of a cGMP-binding activity with an
apparent mass of 160 kDa. This activity could exist in
two interconvertable forms, one with fast dissociation of
cGMP (t1/2 < 1 min) and a Kd of about 6 nM (F-type),
and one with a much slower dissociation rate (t1/2 of
68 min) and a Kd of 2 nM (S-type). Conversion of
F-type to S-type cGMP-binding activity is evoked by
adding DNA, in particular by octamers of deoxyguano-
sine or deoxycytosine (Parissenti and Coukell, 1990).
Moreover, about half of the S-type cGMP-binding
activity was found to be associated with nuclei, suggest-
ing an unexpected nuclear function of the cGMP-binding
protein (Butler and Coukell, 1992). Furthermore, in
ﬁlipin permeabilized cells, the cGMP-binding activity
was found to have a t1/2 for dissociation of cGMP of
about 70 min, indicating that the cGMP-binding activity
might exist in its S-type in vivo. However, this observa-
tion contradicts a study in which the cGMP-binding
capacity at diﬀerent time points after cAMP stimulation
was measured, which indicated a dissociation of cGMP
from the cGMP-binding activity in vivo with a half-life of
about 2 min, which corresponds better to the F-type
cGMP-binding activity (Van Haastert et al., 1982).
In wild-type cells, the partially puriﬁed cGMP-binding
activity activates the particulate GC activity about 2-fold
and the addition of DNA enhances this eﬀect (Kuwa-
yama and Van Haastert, 1996). Furthermore, the same
cGMP-binding fraction inhibits GC activity when ATP
is added, an eﬀect that is enhanced by the addition of
50 nM 8-Br-cGMP. These ﬁndings suggest that the
cGMP-binding protein from Dictyostelium regulates
the Mg2+-dependent GC activity in a complex way.
The identiﬁcation of mutants that have an aberrant
cGMP-binding activity has provided some interesting
information about this regulating activity (Kuwayama
et al., 1995; Kuwayama and Van Haastert, 1996). Two
mutants, KI4 and KI5, have a cGMP-binding activity
with lowered Kd and slow dissociation kinetics. Further-
more, DNA does not alter the dissociation rate, so it
seems the cGMP-binding activity is locked in the S-form
in these mutants. Interestingly, the partially puriﬁed
cGMP-binding fraction from these mutants does not
activate wild-type particulate GC, suggesting that the
cGMP-binding protein is locked in an inhibiting form.
Cloning of the cGMP-binding proteins
Although Dictyostelium lysates contain a highly speciﬁc,
high aﬃnity cGMP-binding activity, PCR reactions
using redundant primers for cGMP-binding domains
have not given any positive result (H. Kuwayama and
P.J.M. Van Haastert, unpublished results). Again the
sequencing of the Dictyostelium discoideum genome has
proven vital to identify genes that do not exactly match
sequence expectations, since the genes of four putative
non-classical cGMP targets have been identiﬁed recently
(Goldberg et al., 2002). These proteins each possess two
tandem cyclic nucleotide binding domains and were
termed Gbp for cGMP-binding protein; the two phos-
phodiesterases PDE5 and PDE6 were already discussed
above. In other identiﬁed cNBDs, including those from
the Dictyostelium discoideum PKA regulatory subunit, a
RXA motif determines the speciﬁcity of the cyclic
nucleotide that is bound (Shabb and Corbin, 1992).
Interestingly, this motif is absent in the Gbps (except for
the ﬁrst nucleotide binding domain of PDE5), and the
homology with the cNBDs of the Gbps is low in this
region, suggesting that the molecular basis of cGMP
binding to Gbps in Dictyostelium is diﬀerent from
cGMP/cAMP binding to the cNBDs of other organ-
isms. In this respect it is interesting to mention that there
is substantial homology in other parts of the cNBDs
between the Gbps. The identiﬁed putative cGMP targets
display a unique topology. The N-terminal half of
GbpC contains ﬁve leucine-rich repeats, a Ras domain
and a protein kinase domain that most closely resembles
a MAPKKK. The C-terminal half consists of a RasGEF
domain and two cNBDs that are separated by a GRAM
domain, which is a small domain that probably plays a
role in protein–protein interactions (Doerks et al.,
2000). The GbpD protein is homologous to the C-
terminal half of GbpC and also contains a RasGEF
domain, a GRAM domain and two cNBDs.
The Ras, RasGEF and MAPKKK domains in GbpC
are homologous to diﬀerent proteins in the metazoan
Ras signaling cascade, in which a RasGEF (Sos)
activates Ras that stimulates a MAPKKK (Raf). This
allows an interesting model in which cGMP binding to
one of the cNBDs stimulates an intramolecular cascade
leading to the activation of MAPKKK. The RasGEF
domain of GbpD may also participate in this reaction
scheme (Figure 4). GbpC could easily function as a
molecular integrator if other RasGEF or Ras proteins,
that are stimulated by other signals, interact with the
domains in GbpC. A model of the main cGMP signaling
components that have now been identiﬁed is represented
in Figure 5.
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Properties of the cGMP-binding proteins
Cell lines in which the GbpC has been disrupted have
lost all high aﬃnity (Kd  4 nM) cGMP-binding capa-
city (Bosgraaf et al., 2002a; Goldberg et al., 2002). The
remaining cGMP-binding capacity has a much lower
aﬃnity (Kd  500 nM) and is probably caused by a
number of proteins including the allosteric and catalytic
sites of PDE5 and PDE6, the regulatory subunit of PKA
and possibly GbpD. However, cGMP binding in a
gbpC)/gbpD) cell is indistinguishable from cGMP-
binding in the gbpC) knock out, which might indicate
that GbpD does not strongly bind cGMP.
The presence of a protein kinase domain in the GbpC
protein raises the question whether it is the previously
identiﬁed cGMP-activated kinase in Dictyostelium. The
mass of GbpC (294 kDa) is considerably larger than
that of the components in the cGMP-activated kinase
preparation (20–130 kDa), but an imaginary proteolytic
product that contains the kinase domain and the ﬁrst
cNBD would weigh only 140 kDa. The cGMP-activated
kinase is activated half-maximally at 1 nM cGMP
(Wanner and Wurster, 1990) and GbpC is the only
protein in Dictyostelium that binds cGMP eﬀectively at
this low concentration. The cGMP-regulated kinase
activity was found to be activated by cAMP as well,
albeit at 20-fold higher concentrations than cGMP,
whereas GbpC binds cAMP with more than 1000-fold
lower aﬃnity than cGMP. Since we cannot exclude that
one of the cNBDs of GbpC binds cGMP with high
aﬃnity and selectivity (which is detected in the intact
protein), while the other binds cGMP with lower aﬃnity
and selectivity (which would be present in the truncated
Fig. 4. Model of the possible functioning of GbpC and GbpD. The
cyclic nucleotide binding domains (cNBD) of the putative cGMP-
binding proteins GbpC and GbpD bind cGMP leading to the
activation of the Ras guanine exchange factor domains (RasGEF),
which activates the small G-protein domain (Ras) of GbpC. This
results in the activation of the kinase domain of GbpC (MAPKKK),
which stimulates a phosphorylation cascade eventually leading to the
phosphorylation of myosin II and chemotaxis.
Fig. 5. Proposed model for the function of the main cGMP signaling molecules. cGMP is produced by the guanylyl cyclase GCA and sGC,
leading to the activation of the cGMP-binding protein GbpC and chemotaxis. cGMP can be degraded by the cGMP-stimulated PDE5 protein
which is distantly related to class II PDEs, and by DdPDE3, a non-stimulated class I PDE.
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protein), it cannot be excluded that the previously
identiﬁed cGMP-regulated protein kinase was part of
GbpC.
The function of cGMP in Dictyostelium
Since cGMP is produced in response to chemotactic
stimulation, it has long been thought that it plays a role
in directed cell movement. Indeed, several chemotaxis
mutants obtained by chemical mutagenesis display
aberrant cGMP responses (Dicou and Brachet, 1982;
Segall et al., 1987; Kuwayama et al., 1993). In one
study, 10 mutants that showed no chemotactic response
to either folic acid or cAMP were examined, nine of
which displayed aberrant cGMP responses (Kuwayama
et al., 1993). In particular, mutant KI8 has no detectable
cGMP anymore due to the absence of all GC activity,
whereas KI10 has a normal GC activity that can no
longer be activated through chemoattractants. Five
other mutants have a very low chemoattractant-induced
cGMP response. The previously mentioned StmF mu-
tants display an enhanced and prolonged cGMP re-
sponse as well as a prolonged elongation in the back of
cAMP waves. However, these mutants show normal
chemotactic behavior when placed in wild-type gene-
rated cAMP waves, indicating that cAMP relay rather
than chemotactic motility is aﬀected in these cells
(Chandrasekhar et al., 1995).
Several studies have indicated that cGMP exerts (part
of) its action through the regulation of myosin II
(reviewed in de la Roche and Cote, 2001). For example,
in mutant KI10 that lacks the chemoattractant induced
cGMP response, the typical phosphorylation and trans-
location of myosin II to the cortex in response to cAMP
stimulation is lost (Liu et al., 1993; Liu and Newell,
1994; Dembinsky et al., 1996). Furthermore, in StmF
mutants the association of myosin II to the cytoskeleton
is prolonged (Ross and Newell, 1981; Liu and Newell,
1991). The identiﬁcation of a myosin light chain kinase
that is indirectly activated by cGMP provides further
evidence for a regulatory role of cGMP on the function
of myosin II (Silveira et al., 1998).
The identiﬁed genes deﬁne the function of cGMP
The cloning of all the main components of the cGMP
signaling pathway has provided an excellent set of tools
to study the eﬀect of cGMP on chemotaxis in Dictyo-
stelium. First of all, cell lines in which the two GCs or
the two cGMP targets GbpC and GbpD are disrupted
can unexpectedly still aggregate, albeit less robustly and
slower than wild type cells (Bosgraaf et al., 2002a;
Roelofs and Van Haastert, 2002). Detailed analysis of
these mutants revealed that in a spatial gradient,
chemotaxis is severely impaired and cells are less
elongated. Furthermore, the cells also move slower in
buﬀer, whereas the response to temporal chemoattrac-
tant ﬂuctuations is essentially normal (L. Bosgraaf
et al., unpublished data). These ﬁndings demonstrate
that the production of cGMP and the presence of the
cGMP targets are critical for eﬃcient chemotaxis. The
mechanism by which the cGMP pathway regulates
chemotaxis was further examined by studying the
phosphorylation and translocation of Myosin II in
several gene knock-out mutants (Bosgraaf et al., 2002a).
In cells that have lost both GCs or GbpC, the
phosphorylation of the myosin II regulatory light chain
(RLC) increases only 30% upon cAMP stimulation
(wild-type 140%). In agreement with this, the pde5)/
pde6) cells that have a greatly enhanced and prolonged
cGMP response, display an increased and especially
prolonged RLC phosphorylation response (153% of
wild-type). The same anomalies were found for myosin
heavy chain phosphorylation, albeit less pronounced.
These ﬁndings conﬁrm the earlier hypothesis that cGMP
is an important factor in the control of myosin II
phosphorylation. However, it probably not the only
component involved, since both gca)/sgc) and gbpc)/
gbpd) cell lines still display a weak myosin II phospho-
rylation response.
Myosin II translocates to the triton insoluble cyto-
skeleton of the cells upon stimulation with a chemo-
attractant (Yumura, 1994). This translocation to the
cortex peaks at 120 s and is preceded by a short release
of myosin II from the triton insoluble cytoskeleton. The
analysis of myosin II translocation to the cortex upon
cAMP stimulation in cGMP-mutants has shed some
light on the role of cGMP in this process (Bosgraaf
et al., 2002a). The results showed that in gca)/sgc) cells
and in gbpc)/gbpd) cells, myosin II does not translocate
to the cortex anymore, but instead a prolonged and
increased release of myosin from the cortex is observed.
The eﬀect of very high cGMP concentrations could be
observed in the pde5)/pde6) cells, which displayed very
low levels of cytoskeleton-associated myosin II in
unstimulated cells and an enhanced and prolonged
translocation upon cAMP stimulation. These ﬁndings
suggest that cGMP and its targets are essential for the
translocation of myosin II to the cortex, and also
indicate that a simple linear relationship between
cGMP-mediated myosin II phosphorylation and -trans-
location to the cortex is not suﬃcient to explain the
observations. The recent ﬁnding that three myosin
heavy chain kinases localize to diﬀerent parts of a
moving cell further support the idea that the function of
myosin II should be considered highly localized and
dynamic (Liang et al., 2002).
Open questions and perspectives
Although we may have identiﬁed the central core in the
cGMP signaling network, which allows the reinterpre-
tation of many older observations, several ﬁndings are
still not well understood. A number of cAMP-mediated
responses have been suggested to be mediated by cGMP.
This includes the cAMP-mediated uptake of Ca2+ ions,
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that appears to be potentiated by cGMP (Kuwayama
and Van Haastert, 1998a). Other issues in which cGMP
might be involved are osmoregulation (Kuwayama and
Van Haastert, 1998b), phototaxis and thermotaxis
(Darcy et al., 1994), the induction of cAMP PDE
activity (Lappano and Coukell, 1982; Van Haastert
et al., 1982), phospolipid methylation (Alemany et al.,
1980), and hyperpolarization (Van Duijn and Wang,
1990). With the now available mutants, it should be
possible to answer these questions. Probably more
diﬃcult to solve is the understanding of the KI mutants
and the mechanism of adaptation of the cGMP re-
sponse.
KI mutants
The KI mutants have demonstrated that cGMP is
involved in chemotaxis (Kuwayama et al., 1993; Kuwa-
yama et al., 1995), but these mutants cannot be easily
understood. KI8 lacks nearly all GC activity, does not
aggregate and shows no chemotaxis to any compound.
However, the gca/sgc double null mutant shows signi-
ﬁcant chemotaxis and aggregation is rather normal
(Bosgraaf et al., 2002; Roelofs and Van Haastert, 2002).
This indicates that the loss of guanylyl cyclase activity is
not the only defect in these mutants, and secondly it
suggests that a mutation in one gene may be responsible
for the loss of activity in two guanylyl cyclases. The
phenotype of KI mutants must be aggregation minus,
because this was the ﬁrst selection step in their isolation,
followed by screening for a chemotaxis defect to folic
acid and cAMP.
Adaptation of the cGMP response
The activation of GC by extracellular cAMP is very
rapid (only 1 s delay) and transient due to the rapid
adaptation of the enzyme (t1/2¼2.4 s) (Van Haastert,
1987). This adaptation probably involves a soluble
fraction since activated GC in permeabilized cells can
only be reactivated by homogenization of the cells and
removal of the soluble fraction (Schoen et al., 1996).
This soluble fraction might be a small G-protein since
overexpression of constitutively active RasD enhances
the desensitization of GC (Van Haastert, 1987). GC
deadapts with a t1/2 of about 90 s, but higher chemo-
attractant concentrations can still activate the adapted
enzyme (Van Haastert, 1987). Although the mechanism
of adaptation is still unknown, some indications sug-
gest that cAMP receptors and G-proteins play an
important role in this process. There exist multiple
kinetic forms of the receptor with diﬀerent aﬃnities and
dissociation rate constants. These receptor forms are
probably cAR1 in diﬀerent states of association with
G-proteins (Van Haastert et al., 1986). It has been
observed that in desensitized cells a speciﬁc transition of
one receptor form to another does no longer take place;
this transition was associated with the activation of the
G-protein. It has been proposed that the adaptation of
GC is caused by this inhibition, which is supported by
the ﬁnding that the blockade is released with a similar
half life as the deadaptation of GC (90 s). The use of a
compound called BAL (2,3-dimercapto-1-propanol) has
provided further evidence that G-proteins play a role in
the adaptation of GC (Oyama, 1991; Oyama et al.,
1991). Addition of this chemical to cells continuously
activates GC, but simultaneous stimulation with cAMP
returns the typical transient GC activation. Apparently,
BAL can somehow activate the GC activity without
activating the pathway leading to its adaptation. Inte-
restingly, addition of cAMP and BAL to Ga2-null cells
causes a continuous activation of GC, which implies
that the Ga2 subunit is required for the both the
activation and adaptation of GC by cAMP. However,
there are several indications that Ga2 is not the only Ga
subunit that plays a role in the regulation of GC. For
example, Ga1 knock-out cells display a 15 s delayed
cAMP induced cGMP response, whereas overexpression
of Ga1 results in a decreased cGMP response with
normal kinetics (Dharmawardhane et al., 1994). Fur-
thermore, overexpression of Ga5, which acts as the
counterpart of the folic acid receptor coupled Ga4,
abolishes the folic acid induced cGMP response (Nata-
rajan et al., 2000). Thus, the GC activity seems to be
regulated by a complex interplay of numerous upstream
proteins, including several G-alpha subunits. The exact
acitvation- and adaptation mechanisms are, however,
still unknown and need further investigation.
Perspectives
The identiﬁcation of the genes encoding cGMP-meta-
bolizing enzymes and target proteins will help to
understand how cGMP regulates myosin phosphoryla-
tion, association of myosin ﬁlaments to the cytoskeleton
and cell locomotion. Several studies are required to
approach this aim. It is essential to derive reliable kinetic
data on the interaction of cGMP with its target proteins
GbpC and GbpD, but also on the function of the
domains in these proteins. In addition, the diﬀusion rate
and the localization of these proteins during chemotaxis
need to be determined. Finally, the interaction of the
cGMP-pathway with the phosphoinositol pathway may
be instrumental for chemotaxis. It is likely that even
with this information, chemotaxis is not easily under-
stood, since it is a complex spatial–temporal process. In
this respect mathematical models may help to get a
feeling for the main regulators of chemotaxis. Previously
we have made a temporal cGMP-model based on
detailed kinetic experiments (Valkema and Van Haas-
tert, 1994). In this model, the kinetics of the cGMP
response are mainly determined by the diﬀerent states of
the receptor, the height and duration of the cGMP
response are mainly determined by the PDEs, and
calcium ions play a role in ﬁne-tuning. An extension of
this model encompassing the spatial properties of cGMP
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